RecruitingNot ApplicableNCT06663969
Evaluating Modulation Effects of Temporal Interference Using SEEG
Sponsor
Xuanwu Hospital, Beijing
Enrollment
20 participants
Start Date
Nov 4, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
This single-center prospective study aims to investigate the electrophysiological mechanisms of temporal interference (TI) in humans by analyzing clinical, imaging, and electrophysiological data from patients aged 14-60 with drug-resistant epilepsy.
Eligibility
Min Age: 14 YearsMax Age: 65 Years
Inclusion Criteria4
- Clinical diagnosis of drug-resistant epilepsy;
- No severe systemic diseases;
- Implantation of stereotactic electrodes;
- Agreement to participate in this study and signs the informed consent form.
Exclusion Criteria1
- Hematoma at the scalp electrode site or fluid accumulation under the electrode after intracranial electrode placement.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERTemporal Interference
Researchers applied temporal interference (TI) stimulation to the deep brain nuclei of patients who had undergone SEEG monitoring, recording changes in electrical activity detected by SEEG.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06663969
Related Trials
A Study of Buntanetap in Participants With PD
NCT0728478427 locations
Low Intensity Focused Ultrasound for Mild Cognitive Impairment and Mild Alzheimer's Disease
NCT054175551 location
A Pilot Study to Evaluate the Efficacy and Safety of NaviFUS™ System Neuromodulating Treatment for Patients With Drug Resistant Epilepsy
NCT064927201 location
A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy
NCT063887073 locations
Udall Project 1 Aim 4
NCT055681991 location